Chris Shaw notes his view to me that "This is very misleading since
neurological disorders and autoimmunity take a long time to manifest."
I guess we can at least say that at this point there is no measurable
signal that indicates any problems, i.e. no numbers that indicate any
measurable rise in "rare neurological conditions" in this 8 million
person data-set so far.
I agree that with this new MRNA technology, given the known ability for
nano-particles to pass the BBB, this should continue to be monitored,
and any measurable effects that might arise should be very closely